(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are Genesco, Nikola, and MicroVision.

The three biggest losers today are Zai Lab, TherapeuticsMD, and Cloudflare.

Winners today

1. Genesco (GCO) – 11.04%

Genesco Inc. operates as a retailer and wholesaler of footwear, apparel, and accessories. The company operates through four segments: Journeys Group, Schuh Group, Johnston & Murphy Group, and Licensed Brands. The Journeys Group segment offers footwear and accessories through the Journeys, Journeys Kidz, and Little Burgundy retail chains, as well as through e-commerce and catalogs for young men, women, and children. The Schuh Group segment operates Schuh retail footwear stores that offer casual and athletic footwear, as well as sells footwear through e-commerce. The Johnston & Murphy Group segment is involved in the retail and e-commerce operations; and wholesale distribution of men's dress and casual footwear, apparel, and accessories, as well as women's footwear and accessories. The Licensed Brands segment markets footwear under the Levi's, Dockers, and G.H. Bass brands for men, women, and children, as well as designs and manufactures the STARTER and ETONIC brands footwear. As of January 29, 2022, the company operated approximately 1,425 retail stores in the United States, Puerto Rico, Canada, the United Kingdom, and the Republic of Ireland primarily under the Journeys, Journeys Kidz, Schuh, Little Burgundy, and Johnston & Murphy names. Its e-commerce websites include journeys.com, journeyskidz.com, journeys.ca, schuh.co.uk, schuh.ie, schuh.eu, johnstonmurphy.com, littleburgundyshoes.com, johnstonmurphy.ca, nashvilleshoewarehouse.com, and dockersshoes.com. Genesco Inc. was incorporated in 1924 and is headquartered in Nashville, Tennessee.

NYSE ended the session with Genesco rising 11.04% to $20.31 on Wednesday, following the last session’s upward trend. NYSE jumped 0.51% to $15,469.63, following the last session’s upward trend on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, Genesco has a trailing twelve months EPS of $3.9.

PE Ratio

Genesco has a trailing twelve months price to earnings ratio of 5.21. Meaning, the purchaser of the share is investing $5.21 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.18%.

Volume

Today’s last reported volume for Genesco is 548888 which is 117.59% above its average volume of 252250.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Genesco’s EBITDA is 0.37.

Sales Growth

Genesco’s sales growth for the current quarter is negative 7.1%.

More news about Genesco.

2. Nikola (NKLA) – 9.17%

Nikola Corporation operates as a technology innovator and integrator that develops energy and transportation solutions. It operates through two business units, Truck and Energy. The Truck business unit develops and commercializes battery electric vehicles (BEV) and hydrogen fuel cell electric vehicles (FCEV) to the trucking sector. The Energy business unit develops and constructs a network of hydrogen fueling stations; and offers BEV charging solutions for its FCEV and BEV customers, as well as other third-party customers. The company also assembles, integrates, and commissions its vehicles in collaboration with its business partners and suppliers. Nikola Corporation founded in 2015 and is headquartered in Phoenix, Arizona.

NASDAQ ended the session with Nikola jumping 9.17% to $0.59 on Wednesday while NASDAQ dropped 1.29% to $13,104.89.

Earnings Per Share

As for profitability, Nikola has a trailing twelve months EPS of $-1.62.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -137.05%.

Sales Growth

Nikola’s sales growth is negative 16.8% for the ongoing quarter and 37.9% for the next.

Volume

Today’s last reported volume for Nikola is 39068800 which is 41% above its average volume of 27706800.

Moving Average

Nikola’s value is way below its 50-day moving average of $0.94 and way below its 200-day moving average of $2.56.

More news about Nikola.

3. MicroVision (MVIS) – 8.71%

MicroVision, Inc. develops and sells lidar sensors used in automotive safety and autonomous driving applications. Its laser beam scanning technology is based on micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company also develops micro-display concepts and designs for head-mounted augmented reality (AR) headsets, as well as 1440i MEMS module supporting AR headsets; interactive display solutions for the smart speakers market; and Consumer Lidar used in smart home systems. In addition, it develops 1st Generation LRL module. The company sells its products primarily to original equipment manufacturers and original design manufacturers. MicroVision, Inc. was founded in 1993 and is headquartered in Redmond, Washington.

NASDAQ ended the session with MicroVision jumping 8.71% to $7.55 on Wednesday while NASDAQ dropped 1.29% to $13,104.89.

Earnings Per Share

As for profitability, MicroVision has a trailing twelve months EPS of $-0.46.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -62.05%.

More news about MicroVision.

4. Roku (ROKU) – 8.39%

Roku, Inc., together with its subsidiaries, operates a TV streaming platform. The company operates in two segments, Platform and Devices. Its streaming platform allows users to find and access TV shows, movies, news, sports, and others. The company also provides digital advertising and related services, including the demand-side ad platform and content distribution services, such as subscription and transaction revenue shares; media and entertainment promotional spending services; premium subscriptions services; video and display advertising services; and sells branded channel buttons on remote controls of streaming device. In addition, it offers billing services; and brand sponsorship and promotions, as well as manufactures, sells, and licenses smart TVs under the Roku TV name. Further, the company provides streaming players, audio products, and smart home products and accessories under the Roku brand name. It offers its products and services through retailers and distributors, as well as directly to customers through its website in the United States, Mexico, Canada, the United Kingdom, Brazil, and Germany. Roku, Inc. was incorporated in 2002 and is headquartered in San Jose, California.

NASDAQ ended the session with Roku jumping 8.39% to $68.26 on Wednesday, after five consecutive sessions in a row of gains. NASDAQ slid 1.29% to $13,104.89, following the last session’s upward trend on what was an all-around bearish trend trading session today.

Earnings Per Share

As for profitability, Roku has a trailing twelve months EPS of $-5.18.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.81%.

Sales Growth

Roku’s sales growth is 1.2% for the current quarter and 16.8% for the next.

Revenue Growth

Year-on-year quarterly revenue growth grew by 1%, now sitting on 3.13B for the twelve trailing months.

Yearly Top and Bottom Value

Roku’s stock is valued at $68.26 at 17:32 EST, way below its 52-week high of $105.85 and way higher than its 52-week low of $38.26.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Roku’s EBITDA is 2.22.

More news about Roku.

5. Ebix (EBIX) – 7.36%

Ebix, Inc., together with its subsidiaries, provides on-demand infrastructure software exchanges and e-commerce services to the insurance, financial, travel, cash remittance, and healthcare industries in the United States and internationally. The company develops and deploys insurance and reinsurance exchanges on an on-demand basis using software-as-a-service (SaaS) enterprise solutions in the areas of customer relationship management, front-end and back-end systems, and outsourced administrative and risk compliance solutions. Its EbixCash exchange related products and services include gift cards; travel exchanges services; money transfer services; foreign exchange and outward remittance services; consumer payment services; and on-demand technology to various providers in the areas of lending, wealth and asset management, and travel. The company's insurance exchanges related products and services include SaaS platform and related services; licensing of software; and professional services comprising setup, customization, training, or consulting. Its risk compliance services cover certificates of insurance creation and tracking; consulting services, such as project management, integration, development, and testing; and business process outsourcing services, including domain intensive project management, system consulting services, and claims adjudication/settlement services. The company was formerly known as Delphi Systems, Inc. and changed its name to Ebix, Inc. in December 2003. Ebix, Inc. was founded in 1976 and is headquartered in Johns Creek, Georgia.

NASDAQ ended the session with Ebix rising 7.36% to $22.02 on Wednesday while NASDAQ fell 1.29% to $13,104.89.

Earnings Per Share

As for profitability, Ebix has a trailing twelve months EPS of $1.71.

PE Ratio

Ebix has a trailing twelve months price to earnings ratio of 12.88. Meaning, the purchaser of the share is investing $12.88 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.31%.

Volume

Today’s last reported volume for Ebix is 389041 which is 24.7% below its average volume of 516717.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Dec 1, 2022, the estimated forward annual dividend rate is 0.3 and the estimated forward annual dividend yield is 1.54%.

More news about Ebix.

6. Brandywine Realty Trust (BDN) – 6.91%

Brandywine Realty Trust (NYSE: BDN) is one of the largest, publicly traded, full-service, integrated real estate companies in the United States with a core focus in the Philadelphia, Austin and Washington, D.C. markets. Organized as a real estate investment trust (REIT), we own, develop, lease and manage an urban, town center and transit-oriented portfolio comprising 163 properties and 23.0 million square feet as of December 31, 2022 which excludes assets held for sale. Our purpose is to shape, connect and inspire the world around us through our expertise, the relationships we foster, the communities in which we live and work, and the history we build together.

NYSE ended the session with Brandywine Realty Trust jumping 6.91% to $4.57 on Wednesday while NYSE rose 0.51% to $15,469.63.

Earnings Per Share

As for profitability, Brandywine Realty Trust has a trailing twelve months EPS of $0.25.

PE Ratio

Brandywine Realty Trust has a trailing twelve months price to earnings ratio of 18.26. Meaning, the purchaser of the share is investing $18.26 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.61%.

Moving Average

Brandywine Realty Trust’s worth is way higher than its 50-day moving average of $4.04 and way below its 200-day moving average of $6.06.

Yearly Top and Bottom Value

Brandywine Realty Trust’s stock is valued at $4.57 at 17:32 EST, way under its 52-week high of $11.23 and way higher than its 52-week low of $3.42.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Apr 3, 2023, the estimated forward annual dividend rate is 0.76 and the estimated forward annual dividend yield is 20.6%.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is a negative 300% and a negative 150%, respectively.

More news about Brandywine Realty Trust.

7. Arcturus Therapeutics (ARCT) – 6.58%

Arcturus Therapeutics Holdings Inc., a late-stage clinical messenger RNA medicines and vaccine company, focuses on the development of infectious disease vaccines and other products within liver and respiratory rare diseases. Its technology platforms include LUNAR lipid-mediated delivery and STARR mRNA. The company is developing ARCT-810 (LUNAR-OTC), a mRNA-based therapeutic candidate, which is in Phase 2 clinical trial for treating ornithine transcarbamylase deficiency; and ARCT-154 (LUNAR-COV19), a mRNA vaccine candidate that is in Phase 3 arm of a Phase 1/2/3 study in Vietnam for the treatment of COVID-19, as well as ARCT-032 (LUNAR-CF), a mRNA therapeutic candidate for cystic fibrosis. The company was founded in 2013 and is headquartered in San Diego, California.

NASDAQ ended the session with Arcturus Therapeutics rising 6.58% to $28.51 on Wednesday, following the last session’s downward trend. NASDAQ dropped 1.29% to $13,104.89, following the last session’s upward trend on what was an all-around negative trend exchanging session today.

Earnings Per Share

As for profitability, Arcturus Therapeutics has a trailing twelve months EPS of $4.11.

PE Ratio

Arcturus Therapeutics has a trailing twelve months price to earnings ratio of 6.94. Meaning, the purchaser of the share is investing $6.94 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 43.3%.

More news about Arcturus Therapeutics.

8. First Bancorp (FBNC) – 6.42%

First Bancorp operates as the bank holding company for First Bank that provides banking products and services for individuals and small to medium-sized businesses. It accepts deposit products, such as checking, savings, and money market accounts, as well as time deposits, including certificate of deposits and individual retirement accounts. The company also offers loans for a range of consumer and commercial purposes comprising loans for business, real estate, personal, home improvement, and automobiles, as well as residential mortgages and small business administration loans; and accounts receivable financing and factoring, inventory financing, and purchase order financing services. In addition, it provides credit and debit cards, letter of credits, and safe deposit box rental services, as well as electronic funds transfer services consisting of wire transfers; and internet and mobile banking, cash management, bank-by-phone services, and remote deposit capture services. Further, the company offers investment and insurance products, such as mutual funds, annuities, long-term care insurance, life insurance, and company retirement plans, as well as property and casualty insurance products; and financial planning services. First Bancorp was founded in 1934 and is headquartered in Southern Pines, North Carolina.

NASDAQ ended the session with First Bancorp jumping 6.42% to $35.33 on Wednesday while NASDAQ fell 1.29% to $13,104.89.

Earnings Per Share

As for profitability, First Bancorp has a trailing twelve months EPS of $3.54.

PE Ratio

First Bancorp has a trailing twelve months price to earnings ratio of 9.98. Meaning, the purchaser of the share is investing $9.98 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.6%.

More news about First Bancorp.

9. Stanley Black & Decker (SWK) – 6.1%

Stanley Black & Decker, Inc. engages in the tools and storage and industrial businesses in the United States, Canada, rest of Americas, France, rest of Europe, and Asia. Its Tools & Storage segment offers professional products, including professional grade corded and cordless electric power tools and equipment, and pneumatic tools and fasteners; and consumer products, such as corded and cordless electric power tools primarily under the BLACK+DECKER brand, as well as corded and cordless lawn and garden products and related accessories; home products; and hand tools, power tool accessories, and storage products. This segment sells its products through retailers, distributors, dealers, and a direct sales force to professional end users, distributors, dealers, retail consumers, and industrial customers in various industries. The company's Industrial segment provides engineered fastening systems and products to customers in the automotive, manufacturing, electronics, construction, aerospace, and other industries; provides pipeline inspection services; and sells hydraulic tools and performance-driven heavy equipment attachment tools. This segment serves oil and natural gas pipeline industry and other industrial customers. It also sells automatic doors to commercial customers. The company was formerly known as The Stanley Works and changed its name to Stanley Black & Decker, Inc. in March 2010. Stanley Black & Decker, Inc. was founded in 1843 and is headquartered in New Britain, Connecticut.

NYSE ended the session with Stanley Black & Decker rising 6.1% to $86.94 on Wednesday while NYSE rose 0.51% to $15,469.63.

Earnings Per Share

As for profitability, Stanley Black & Decker has a trailing twelve months EPS of $-1.15.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.84%.

Sales Growth

Stanley Black & Decker’s sales growth is negative 6% for the current quarter and 1.5% for the next.

Yearly Top and Bottom Value

Stanley Black & Decker’s stock is valued at $86.94 at 17:32 EST, way below its 52-week high of $123.08 and way higher than its 52-week low of $70.24.

More news about Stanley Black & Decker.

10. Novavax (NVAX) – 5.95%

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 and influenza combined. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, Adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also focusing on products candidates for respiratory syncytial virus and malaria. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

NASDAQ ended the session with Novavax rising 5.95% to $7.66 on Wednesday while NASDAQ slid 1.29% to $13,104.89.

Earnings Per Share

As for profitability, Novavax has a trailing twelve months EPS of $-13.35.

More news about Novavax.

Losers Today

1. Zai Lab (ZLAB) – -12.4%

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. Its commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; and Qinlock to treat gastrointestinal stromal tumors. The company also develops Odronextamab to treat follicular lymphoma, diffuse large B-cell lymphoma, and other B-celllymphomas; Repotrectinib, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naïve- or -pretreated cancer patients; Margetuximab for the treatment of breast and gastroesophageal cancers; Tisotumab vedotin, an antibody drug conjugate; Adagrasib for treating KRAS-G12C-mutated NSCLC, colorectal cancer, pancreatic cancer, and other solid tumors; and Bemarituzumab to treat gastric and gastroesophageal junction cancer. In addition, it develops Zipalertinib for the treatment of patients with EGFR exon 20 insertion NSCLC; Elzovantinib, an orally bioavailable multi-targeted kinase inhibitor; ZL-2313, an investigational oral EGFR inhibitor; ZL-1211, a humanized IgG1 monoclonal antibody that targets CLDN18.2; ZL-1218 is humanized IgG1 monoclonal antibody to induce potent antibody-dependent cellular cytotoxicity activity that enables NK cell-mediated killing of CCR8-expressing T-regs; Efgartigimod to reduce disease-causing immunoglobulin G antibodies; ZL-1102, a human nanobody targeting interleukin- 17A; Sulbactam/durlobactam for the treatment of serious infections caused by Acinetobacter; and KarXT for the treatment of psychiatric and neurological conditions. The company was incorporated in 2013 and is headquartered in Shanghai, China.

NASDAQ ended the session with Zai Lab sliding 12.4% to $29.38 on Wednesday while NASDAQ dropped 1.29% to $13,104.89.

Earnings Per Share

As for profitability, Zai Lab has a trailing twelve months EPS of $-4.27.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -35.51%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Zai Lab’s stock is considered to be overbought (>=80).

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 50.7% and 57.1%, respectively.

Sales Growth

Zai Lab’s sales growth is 50.7% for the current quarter and 47.5% for the next.

Volume

Today’s last reported volume for Zai Lab is 929095 which is 51.9% above its average volume of 611649.

More news about Zai Lab.

2. TherapeuticsMD (TXMD) – -10.37%

TherapeuticsMD, Inc. operates as a pharmaceutical company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY,BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

NASDAQ ended the session with TherapeuticsMD sliding 10.37% to $3.99 on Wednesday, following the last session’s upward trend. NASDAQ slid 1.29% to $13,104.89, following the last session’s upward trend on what was an all-around down trend exchanging session today.

Earnings Per Share

As for profitability, TherapeuticsMD has a trailing twelve months EPS of $1.99.

PE Ratio

TherapeuticsMD has a trailing twelve months price to earnings ratio of 2. Meaning, the purchaser of the share is investing $2 for every dollar of annual earnings.

Volume

Today’s last reported volume for TherapeuticsMD is 70291 which is 87.87% above its average volume of 37414.

More news about TherapeuticsMD.

3. Cloudflare (NET) – -8.36%

CloudFlare, Inc. operates as a cloud services provider that delivers a range of services to businesses worldwide. The company provides an integrated cloud-based security solution to secure a range of combination of platforms, including public cloud, private cloud, on-premise, software-as-a-service applications, and IoT devices; and website and application security products comprising web application firewall, bot management, distributed denial of service, API gateways, SSL/TLS encryption, secure origin connection, and rate limiting products. It also offers website and application performance solutions, including content delivery, load balancing, DNS, agro smart routing, video stream delivery, content optimization, virtual backbone, always online, and cloudflare waiting room and registrar; and network services, which deliver network connectivity, security, and performance to customers as a service, including WAN, WARP, magic transit, magic firewall, cloudflare network interconnect, and spectrum. In addition, the company provides zero trust services, such as cloudflare access, cloudflare gateway, remote browser isolation, cloud access security broker, cloudflare area 1 email security, and data loss prevention products that protect, inspect, and privilege data. Further, it provides developer-based solutions consisting of cloudflare workers, pages, stream, and images, as well as Cloudflare Data Localization suite, a tool that set rules and controls at the network edge; durable objects and R2 object storage products; Consumer DNS Resolver, a consumer app to browse the Internet; and consumer VPN for consumers to secure and accelerate traffic on mobile devices. The company serves customers in the technology, healthcare, financial services, consumer and retail, and non-profit industries, as well as government. CloudFlare, Inc. was incorporated in 2009 and is headquartered in San Francisco, California.

NYSE ended the session with Cloudflare dropping 8.36% to $62.88 on Wednesday, after four consecutive sessions in a row of losses. NYSE rose 0.51% to $15,469.63, following the last session’s upward trend on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, Cloudflare has a trailing twelve months EPS of $-0.57.

Volatility

Cloudflare’s last week, last month’s, and last quarter’s current intraday variation average was 0.36%, 2.50%, and 3.25%.

Cloudflare’s highest amplitude of average volatility was 1.06% (last week), 3.22% (last month), and 3.25% (last quarter).

Sales Growth

Cloudflare’s sales growth is 30.3% for the current quarter and 31.5% for the next.

More news about Cloudflare.

4. Datadog (DDOG) – -8.29%

Datadog, Inc. operates an observability and security platform for cloud applications in North America and internationally. The company's products include infrastructure and application performance monitoring, log management, digital experience monitoring, continuous profiler, database monitoring, network monitoring, incident management, observability pipelines, cloud cost management, universal service monitoring, cloud security management, application security management. cloud SIEM, sensitive data scanner, and CI Visibility. The company was incorporated in 2010 and is headquartered in New York, New York.

NASDAQ ended the session with Datadog dropping 8.29% to $93.41 on Wednesday while NASDAQ slid 1.29% to $13,104.89.

Earnings Per Share

As for profitability, Datadog has a trailing twelve months EPS of $-0.27.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -6.39%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 32.7%, now sitting on 1.79B for the twelve trailing months.

More news about Datadog.

5. FibroGen (FGEN) – -8.28%

FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Pamrevlumab, a human monoclonal antibody targeting connective tissue growth factor that is in Phase III clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, and Duchenne muscular dystrophy; and Roxadustat, an oral small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in China, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.

NASDAQ ended the session with FibroGen falling 8.28% to $17.16 on Wednesday, following the last session’s downward trend. NASDAQ dropped 1.29% to $13,104.89, following the last session’s upward trend on what was an all-around negative trend trading session today.

: fibrogen shares slide after duchenne muscular dystrophy treatment falls short in trialShares of FibroGen Inc. were down 5.6% premarket on Wednesday after the company announced disappointing results from a late-stage trial of pamrevlumab in non-ambulatory patients with Duchenne muscular dystrophy. , While disappointed with these results, we look forward to sharing the data at a future medical conference to contribute towards the understanding of this devastating disease, FibroGen CEO Enrique Conterno said in a statement.

Earnings Per Share

As for profitability, FibroGen has a trailing twelve months EPS of $-3.39.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -411.93%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

FibroGen’s EBITDA is 11.97.

More news about FibroGen.

6. Groupon (GRPN) – -7.52%

Groupon, Inc., together with its subsidiaries, operates a marketplace that connects consumers to merchants. It operates in two segments, North America and International. The company sells goods or services on behalf of third-party merchants; and first-party goods inventory. It serves customers through its mobile applications and websites. The company was formerly known as ThePoint.com, Inc. and changed its name to Groupon, Inc. in October 2008. Groupon, Inc. was incorporated in 2008 and is headquartered in Chicago, Illinois.

NASDAQ ended the session with Groupon falling 7.52% to $5.66 on Wednesday while NASDAQ dropped 1.29% to $13,104.89.

Earnings Per Share

As for profitability, Groupon has a trailing twelve months EPS of $-7.92.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -285.15%.

Yearly Top and Bottom Value

Groupon’s stock is valued at $5.66 at 17:32 EST, way below its 52-week high of $16.45 and way higher than its 52-week low of $2.89.

Moving Average

Groupon’s value is way higher than its 50-day moving average of $3.97 and way under its 200-day moving average of $7.11.

Sales Growth

Groupon’s sales growth is negative 19.3% for the current quarter and negative 14.5% for the next.

More news about Groupon.

7. Zscaler (ZS) – -5.96%

Zscaler, Inc. operates as a cloud security company worldwide. It offers Zscaler Internet Access solution that provides users, workloads, IoT, and OT devices secure access to externally managed applications, including software-as-a-service (SaaS) applications and internet destinations; and Zscaler Private Access solution, which is designed to provide access to managed applications hosted internally in data centers, and private or public clouds. The company also provides Zscaler Digital Experience that measures end-to-end user experience across business applications, as well as provides an easy to understand digital experience score for each user, application, and location within an enterprise. In addition, it offers Posture Control solutions comprising Cloud Security Posture Management that identifies and remediates application misconfigurations in SaaS, infrastructure as a service, and PaaS to reduce risk and ensure compliance with industry and organizational benchmarks; Cloud Infrastructure Entitlement Management that detects and remediates excessive or unused cloud permissions and enforces least privileged access without disrupting productivity; Infrastructure as Code (IaC), which analyzes IaC templates to identify misconfigurations and other security issues prior to deployment to cloud infrastructure; and Vulnerability Scanning and Data Loss Prevention solutions. The company's platform modules include Zscaler Central Authority, Zscaler Enforcement Node, and Zscaler Log Servers. It serves customers in airlines and transportation, conglomerates, consumer goods and retail, financial services, healthcare, manufacturing, media and communications, public sector and education, technology, and telecommunications services industries. The company was formerly known as SafeChannel, Inc., and changed its name to Zscaler, Inc. in August 2008. Zscaler, Inc. was incorporated in 2007 and is headquartered in San Jose, California.

NASDAQ ended the session with Zscaler sliding 5.96% to $143.87 on Wednesday while NASDAQ fell 1.29% to $13,104.89.

Earnings Per Share

As for profitability, Zscaler has a trailing twelve months EPS of $-2.57.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -60.8%.

More news about Zscaler.

8. Intuit (INTU) – -5.71%

Intuit Inc. provides financial management and compliance products and services for consumers, small businesses, self-employed, and accounting professionals in the United States, Canada, and internationally. The company operates in four segments: Small Business & Self-Employed, Consumer, Credit Karma, and ProConnect. The Small Business & Self-Employed segment provides QuickBooks online services and desktop software solutions comprising QuickBooks Online Advanced, a cloud-based solution; QuickBooks Enterprise, a hosted solution; QuickBooks Self-Employed solution; QuickBooks Commerce, a solution for product-based businesses; QuickBooks Online Accountant; and payroll solutions, such as online payroll processing, direct deposit of employee paychecks, payroll reports, electronic payment of federal and state payroll taxes, and electronic filing of federal and state income tax returns. This segment also offers payment-processing solutions, including credit and debit cards, Apple Pay, and ACH payment services; QuickBooks Cash business bank account; and financial supplies and financing for small businesses. The Consumer segment provides TurboTax income tax preparation products and services; and personal finance. The Credit Karma segment offers consumers with a personal finance platform that provides personalized recommendations of home, auto, and personal loans, as well as credit cards and insurance products. The ProConnect segment provides Lacerte, ProSeries, and ProFile desktop tax-preparation software products; and ProConnect Tax Online tax products, electronic tax filing service, and bank products and related services. It sells products and services through various sales and distribution channels, including multi-channel shop-and-buy experiences, websites and call centers, mobile application stores, and retail and other channels. The company was founded in 1983 and is headquartered in Mountain View, California.

NASDAQ ended the session with Intuit sliding 5.71% to $422.90 on Wednesday while NASDAQ dropped 1.29% to $13,104.89.

Earnings Per Share

As for profitability, Intuit has a trailing twelve months EPS of $7.89.

PE Ratio

Intuit has a trailing twelve months price to earnings ratio of 53.6. Meaning, the purchaser of the share is investing $53.6 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.96%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 31.8% and 22.9%, respectively.

More news about Intuit.

9. Marathon (MARA) – -5.31%

Marathon Digital Holdings, Inc. operates as a digital asset technology company that mines digital assets with a focus on the blockchain ecosystem and the generation of digital assets in United States. The company was formerly known as Marathon Patent Group, Inc. and changed its name to Marathon Digital Holdings, Inc. in February 2021. Marathon Digital Holdings, Inc. was incorporated in 2010 and is headquartered in Fort Lauderdale, Florida.

NASDAQ ended the session with Marathon falling 5.31% to $9.55 on Wednesday while NASDAQ dropped 1.29% to $13,104.89.

Earnings Per Share

As for profitability, Marathon has a trailing twelve months EPS of $-6.56.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -103.2%.

Volatility

Marathon’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.75%, a negative 0.24%, and a positive 6.59%.

Marathon’s highest amplitude of average volatility was 5.32% (last week), 5.55% (last month), and 6.59% (last quarter).

Yearly Top and Bottom Value

Marathon’s stock is valued at $9.55 at 17:32 EST, way under its 52-week high of $18.88 and way above its 52-week low of $3.11.

Revenue Growth

Year-on-year quarterly revenue growth declined by 1.1%, now sitting on 117.16M for the twelve trailing months.

More news about Marathon.

10. Shopify (SHOP) – -5.21%

Shopify Inc., a commerce company, provides a commerce platform and services in Canada, the United States, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. The company's platform enables merchants to displays, manages, markets, and sells its products through various sales channels, including web and mobile storefronts, physical retail locations, pop-up shops, social media storefronts, native mobile apps, buy buttons, and marketplaces; and enables to manage products and inventory, process orders and payments, fulfill and ship orders, new buyers and build customer relationships, source products, leverage analytics and reporting, manage cash, payments and transactions, and access financing. It also sells custom themes and apps, and registration of domain names; and merchant solutions, which include accepting payments, shipping and fulfillment, and securing working capital. The company was formerly known as Jaded Pixel Technologies Inc. and changed its name to Shopify Inc. in November 2011. Shopify Inc. was incorporated in 2004 and is headquartered in Ottawa, Canada.

NYSE ended the session with Shopify sliding 5.21% to $60.35 on Wednesday while NYSE rose 0.51% to $15,469.63.

Earnings Per Share

As for profitability, Shopify has a trailing twelve months EPS of $-1.66.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.03%.

Volume

Today’s last reported volume for Shopify is 13146400 which is 18.96% below its average volume of 16222500.

Revenue Growth

Year-on-year quarterly revenue growth grew by 25.2%, now sitting on 5.9B for the twelve trailing months.

Moving Average

Shopify’s worth is way above its 50-day moving average of $52.44 and way above its 200-day moving average of $40.98.

More news about Shopify.

Stay up to date with our winners and losers daily report